European TB Pharmaceutical Management Conference

Fighting Drug-Resistant TB in the 21st Century: Novel Approaches to Improving Access to anti-TB Medicines and Pharmaceutical Services 1st Conference on Pharmaceutical Management for TB and M/XDR-TB for WHO European Region Antalya, Turkey, 10 – 13 December, 2013 The highest rate of multi drug-resistant and extensively drug-resistant (M/XDR-TB) cases of tuberculosis is found in the … Read more

QuanTB in the News

UNITAID’s premier global newsletter, “The Market Share,” highlights SIAPS’ cutting-edge QuanTB, an electronic forecasting, quantification, and early warning tool designed to improve procurement processes, ordering and planning for TB treatment, and avoid stock-outs or waste of medicines. QuanTB was developed by the SIAPS team to transform complicated calculations into a user-friendly dashboard displaying key information … Read more

SIAPS Helping to Save Newborn Lives in the DRC

Kinshasa, Democratic Republic of the Congo (DRC), November 15, 2013 — US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) is helping the Government of the DRC save newborn lives. By using a common antiseptic, 7.1 percent Chlorhexidine (CHX) for cleaning a baby’s newly cut umbilical cord, infant mortality … Read more

Pharmacists, drug sellers, and pharmacy associations: Key players in the fight against TB

Reposted from MSH at the Union World Conference on Lung Health 2013. While the National Tuberculosis Programs (NTP) of most countries offer free diagnosis and treatment for tuberculosis (TB), many people worldwide first seek care from other providers, such as physicians in the private sector, pharmacists, or informal drug sellers. Partnerships between NTPs and providers … Read more

Covering All the Bases: Ensuring Availability of TB Medicines

Reposted from MSH at the Union World Conference on Lung Health 2013. When purchasing a medicine from the shelf of a local pharmacy, it’s easy to forget the many miles traveled and challenges overcome to make it available to consumers. This is especially true for tuberculosis medicines, which come from a limited number of manufacturers and … Read more